Literature DB >> 21540308

T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis.

E Kriegova1, R Fillerova, T Tomankova, B Hutyrova, F Mrazek, T Tichy, V Kolek, R M du Bois, M Petrek.   

Abstract

Upregulation of genes for interferon (IFN)-γ and CXC chemokine receptor (CXCR)3 expression, two crucial molecules in sarcoid inflammation and granuloma formation, is directly controlled by the T-helper (Th)1 transcription factor T-bet (T-box, expressed in T-cells). However, there is no information on T-bet expression in sarcoidosis or its relationship with "sarcoidosis-associated" genes. Therefore, we investigated expression of T-bet mRNA and, in parallel, a spectrum of genes known to be involved in sarcoidosis pathogenesis. Transcripts were determined in bronchoalveolar lavage (BAL) cells from 62 sarcoidosis patients and 25 controls by quantitative RT-PCR; T-bet protein was localised by immunohistochemistry. Patient's BAL cells expressed higher mRNA T-bet levels than those of controls (mean ± sd fold change 3.64 ± 1.72; p = 0.00006). T-bet mRNA expression did not vary between clinical phenotypes as assessed by chest radiography stage, presence/absence of Löfgren's syndrome, extrapulmonary/pulmonary involvement or progressing/remitting disease (p > 0.05). T-bet mRNA expression correlated with expression of IFN-γ, CC chemokine ligand 5, CXC chemokine ligand (CXC)10, interleukin (IL)-2 receptor/IL-15 receptor β, CXCR3 and CXCR6 (p < 0.01). T-bet protein was localised to alveolar macrophages and lymphocytes, tissue multinucleated giant cells, macrophages and lymphocytes. In pulmonary sarcoidosis, T-bet upregulation is associated with changes in expression of IFN-γ, CXCR3 and chemokines/receptors involved in the pathogenesis of sarcoidosis, which suggests a role for T-bet in this Th1 disease, including modulation of some sarcoidosis-associated genes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21540308     DOI: 10.1183/09031936.00089910

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

1.  Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.

Authors:  George P Christophi; Tiffany Caza; Christopher Curtiss; Divya Gumber; Paul T Massa; Steve K Landas
Journal:  Exp Mol Pathol       Date:  2014-04-21       Impact factor: 3.362

2.  Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis.

Authors:  Nicholas K Arger; Melissa Ho; Prescott G Woodruff; Laura L Koth
Journal:  Respir Med       Date:  2019-04-17       Impact factor: 3.415

3.  IL-36γ/IL-1F9, an innate T-bet target in myeloid cells.

Authors:  Malte Bachmann; Patrick Scheiermann; Lorena Härdle; Josef Pfeilschifter; Heiko Mühl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

4.  CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis.

Authors:  Nicholas K Arger; Melissa E Ho; Isabel E Allen; Bryan S Benn; Prescott G Woodruff; Laura L Koth
Journal:  Respir Med       Date:  2019-11-20       Impact factor: 3.415

5.  NOD2 is highly expressed in Behçet disease with pulmonary manifestations.

Authors:  Kamel Hamzaoui; Hanadi Abid; Anissa Berraies; Jamel Ammar; Agnès Hamzaoui
Journal:  J Inflamm (Lond)       Date:  2012-02-13       Impact factor: 4.981

Review 6.  Sarcoidosis: Immunopathogenesis and Immunological Markers.

Authors:  Wei Sheng Joshua Loke; Cristan Herbert; Paul S Thomas
Journal:  Int J Chronic Dis       Date:  2013-07-25

Review 7.  Granuloma formation in pulmonary sarcoidosis.

Authors:  Caroline E Broos; Menno van Nimwegen; Henk C Hoogsteden; Rudi W Hendriks; Mirjam Kool; Bernt van den Blink
Journal:  Front Immunol       Date:  2013-12-10       Impact factor: 7.561

8.  Correlation Network Analysis Reveals Relationships between MicroRNAs, Transcription Factor T-bet, and Deregulated Cytokine/Chemokine-Receptor Network in Pulmonary Sarcoidosis.

Authors:  Tereza Dyskova; Regina Fillerova; Tomas Novosad; Milos Kudelka; Monika Zurkova; Petr Gajdos; Vitezslav Kolek; Eva Kriegova
Journal:  Mediators Inflamm       Date:  2015-11-30       Impact factor: 4.711

9.  T-bet and interleukin-27: possible TH1 immunomodulators of sarcoidosis.

Authors:  Wei Sheng Joshua Loke; Araluen Freeman; Linda Garthwaite; Silvie Prazakova; Mijeong Park; Kenneth Hsu; Paul S Thomas; Cristan Herbert
Journal:  Inflammopharmacology       Date:  2015-08-09       Impact factor: 4.473

10.  Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases.

Authors:  Arsen Arakelyan; Lilit Nersisyan; Martin Petrek; Henry Löffler-Wirth; Hans Binder
Journal:  Front Genet       Date:  2016-05-06       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.